title: Improved benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10.
abstract: BACKGROUND
  Accurate estimates of the size of the drug-using populations are essential for evidence-based policy making. However, drug users form a 'hidden' population, necessitating the use of indirect methods to estimate population sizes.
  
  
  METHODS
  The benchmark-multiplier method was applied to estimate the population size of ever injecting drug users (ever-IDUs), aged 18-64 years, in Belgium using data from the national HIV/AIDS register and from a sero-behavioral study among injecting drug users. However, missing risk factor information and absence of follow-up of the HIV+/AIDS- cases, limits the usefulness of the Belgian HIV/AIDS register as benchmark. To overcome these limitations, statistical corrections were required. In particular, Imputation by Chained Equations was used to correct for the missing risk factor information whereas stochastic mortality modelling was applied to account for the mortality among the HIV+/AIDS- cases. Monte Carlo simulation was used to obtain confidence intervals, properly reflecting the uncertainty due to random error as well as the uncertainty associated with the two statistical corrections mentioned above.
  
  
  RESULTS
  In 2010, the prevalence (/1000) of ever-IDUs was estimated to be 3.5 with 95% confidence interval [2.5;4.8]. No significant time trends were observed for the period 2000-2010.
  
  
  CONCLUSIONS
  To be able to estimate the ever-IDU population size using the Belgian HIV/AIDS register as benchmark, statistical corrections were required without which seriously biased estimates would result. By developing the improved methodology, Belgium is again able to provide ever-IDU population estimates, which are essential to assess the coverage of treatment and to forecast health care needs and costs.
authors: OD Public Health and Surveillance, Scientific Institute Public Health, Rue Juliette Wytsmanstraat 14, Brussels B-1050, Belgium. kaatje.bollaerts@wiv-isp.be.
authors: Kaatje
authors: K
authors: Bollaerts
authors: Marc
authors: M
authors: Aerts
authors: Andre
authors: A
authors: Sasse
references: Eur Addict Res. 2012;18(6):288-96
references: 22854631
references: Eur Addict Res. 2004;10(2):61-7
references: 15004449
references: Am J Epidemiol. 1973 Jul;98(1):56-62
references: 4780928
references: Sex Transm Infect. 2006 Jun;82 Suppl 3:iii56-63
references: 16735295
references: Addiction. 2003 Apr;98(4):471-85
references: 12653817
references: Int J Methods Psychiatr Res. 2011 Mar;20(1):40-9
references: 21499542
references: Addiction. 2008 Oct;103(10):1604-13
references: 18638037
references: J Epidemiol Community Health. 2004 Sep;58(9):766-71
references: 15310803
references: Stat Methods Med Res. 2007 Jun;16(3):219-42
references: 17621469
references: Lancet. 1985 Jan 26;1(8422):203-5
references: 2857274
references: J Subst Abuse Treat. 2013 Jul;45(1):19-30
references: 23462151
references: Stat Med. 1999 Mar 30;18(6):681-94
references: 10204197
references: Eur J Public Health. 2011 Oct;21(5):646-8
references: 20551045
references: Drug Alcohol Rev. 2006 Mar;25(2):131-40
references: 16627302
references: Med J Aust. 2000 Nov 20;173(10):528-31
references: 11194736